Singapore, April 10 -- NEXTBIOMEDICAL, an innovative medical device company based in South Korea, has entered into an exclusive distribution agreement in Japan with Asahi Intecc Co, a global medical device company, for Nexsphere-F™, the company's novel fast-resorbable microsphere for embolization.

Unlike many biotechnology companies that generate revenue through technology transfer and royalties, NEXTBIOMEDICAL differentiates itself by exporting finished medical devices directly. This agreement follows the same model, under which the company will supply finished products to its Japanese partner.

Asahi Intecc specialises in medical microcatheters and guidewires and has established a strong global presence across Japan, the United S...